Filters

DPYD Antibody

DPYD Antibody size: 0.1ml 263

Price 263
Size 0.1ml
Long nameDPYD Primary Polyclonal Antibody
Also known asDPYD PAb
CategoryPrimary Antibodies
ConjugationUnconjugated
Target AntigenDPYD
SpecificityThis is a highly specific antibody against DPYD
Modification(s)None
Modification site(s)Unmodified antibody
ClonalityPolyclonal antibody
Clone numberPolyclonal antibody
Concentration1ug per 1ul
SourceThis antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human DPYD
Gene ID number1806
Tested Applications IF(IHC-P), IHC-P, WB
Recommended dilutions IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000)
Cross reactivity Mouse, Rat, Human
Cross reactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Background of the target antigen Abnormal concentrations of these metabolites in bodily fluids may be the cause of neurological disease and a contraindication for treatment of cancer patients with certain pyrimidine analogs, DPYD also catalyzes the anticancer agent 5-fluorouracil (5-FU) pathway and is involved in the efficacy and toxicity of 5-FU, DPYD deficiency is a disease characterized by persistent urinary excretion of excessive amounts of uracil, Deficient DPYD alleles may constitute a risk factor for severe toxicity following treatment with 5-FU, Leukopenia, Patients suffering from this disease show a severe reaction to the anticancer drug 5-fluorouracil, Specifically, This reaction includes stomatitis, Variations in DPYD concentration may arise from alterations at the transcriptional level of the dihydropyrimidine dehydrogenase gene, a deficiency of DPYD leads to an accumulation of uracil and thymine, also known as hereditary thymine-uraciluria or familial pyrimidinemia, and neurologic symptoms, cerebellar ataxia, diarrhea, fever, hair loss, hypermethylation of the DPYD promoter downregulates dihydropyrimidine dehydrogenase expression, marked weight loss, progressing to semicoma, thrombocytopenia, thus, thymine and 5-hydroxymethyluracil, Dihydropyrimidine dehydrogenase (DPYD) catalyzes the first rate-limiting step of the NADPH-dependent catabolism of uracil and thymine to dihydrouracil and dihydrothymine, Involvement in disease:Defects in DPYD are the cause of dihydropyrimidine dehydrogenase deficiency (DPYD deficiency)
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA
Synonym names DHPDHase, DPD, DPYD, DPYD_HUMAN, Dihydropyrimidine dehydrogenase, Dihydropyrimidine dehydrogenase [NADP+], Dihydrothymine dehydrogenase, Dihydrouracil dehydrogenase, MGC132008, MGC70799, OTTHUMP00000058954, DHP
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°
Gene targetDPYD
Short nameDPYD Antibody
Technique antibodies against human proteins, antibodies for, Antibody
Alternative nameDPYD (Antibody to)
Alternative techniqueantibodies
Identity 3012
Gene DPYD
Long gene name dihydropyrimidine dehydrogenase
Synonyms DPD
Locus 1p21, 3
Discovery year 1994-07-07
GenBank acession U20938
Entrez gene record 1806
Pubmed identfication 7713523
RefSeq identity NM_000110
Havana BLAST/BLAT OTTHUMG00000039683
Locus Specific Databases UMD Locus Specific Databases LRG_722

Subscribe to our Newsletter